What Is the Cagrilintide Peptide?
Cagrilintide is a long-acting synthetic analog of amylin, also known as islet amyloid polypeptide (IAPP). Native amylin is a 37-amino-acid peptide hormone co-secreted with insulin from pancreatic beta cells in response to nutrient intake, and it participates in the regulation of energy balance and glucose homeostasis.
Because native amylin is aggregation-prone and poorly soluble, Cagrilintide is engineered for stability and prolonged action. Its sequence is modified and acylated with a fatty-acid side chain that binds reversibly to serum albumin, substantially extending its circulating half-life and enabling infrequent, long-acting dosing schedules in research settings. Classified as a long-acting amylin-receptor agonist, Cagrilintide has become a prominent subject of metabolic research - particularly in studies exploring complementary appetite and metabolic pathways. Amino Labs supplies Cagrilintide strictly as a compound for laboratory research, not for human or animal consumption.
Recommended Products
Mechanisms and Pathways Researchers Explore
Amylin signals through amylin receptors (AMY receptors), heteromeric complexes formed by the calcitonin receptor (CTR) core combined with a receptor activity-modifying protein (RAMP1, RAMP2, or RAMP3), which give rise to the AMY1, AMY2, and AMY3 subtypes. Cagrilintide is studied as a non-selective agonist across these amylin receptors, with activity also at the calcitonin receptor itself. Receptor activation is Gs-coupled, elevating cAMP, and central amylin signaling in the area postrema and hypothalamic circuits provides the mechanistic basis for the effects researchers examine.
Key areas of preclinical and scientific research investigation include:
- Satiety and food intake - central amylin signaling and its role in meal termination is the core research area.
- Gastric emptying - amylin’s slowing of gastric emptying, studied as a mechanism influencing postprandial nutrient dynamics.
- Glucagon regulation - amylin’s suppression of postprandial glucagon secretion, relevant to glucose-homeostasis research.
A substantial focus of research is combination pharmacology. Because amylin analogs act on the CTR/RAMP system - a pathway distinct from the GLP-1 receptor - they are investigated as complementary rather than redundant to GLP-1 agonism. The co-formulation of Cagrilintide with Semaglutide (studied as CagriSema) is a prominent example, examined on the hypothesis that two complementary appetite and metabolic pathways may produce additive effects. Researchers frequently compare it with dual and triple incretin agonists such as Tirzepatide.
Research Handling, Storage, and Quality Considerations
Cagrilintide is supplied as a lyophilized powder. The dry lyophilate should be stored sealed, frozen or refrigerated, and protected from light, heat, and humidity. Because peptides are hygroscopic, maintaining a desiccated, sealed environment is an important handling consideration.
For research use, the powder is reconstituted with sterile or bacteriostatic water. Reconstituted solutions are generally kept refrigerated at approximately 2-8°C, used within a limited window, and protected from repeated freeze-thaw cycles. Notably, amylin-family peptides are historically aggregation-prone - native IAPP is amyloidogenic - so minimizing agitation, foaming, and prolonged room-temperature exposure of solutions is an especially relevant consideration for this class.
Given this sensitivity, compound quality is particularly important. Amino Labs provides Cagrilintide at 99%+ HPLC-verified purity, lyophilized and third-party tested, with batch documentation available. As a Canadian-owned supplier shipping across Canada via Purolator, we emphasize analytical transparency. These are general laboratory conventions; researchers should defer to the specific Certificate of Analysis accompanying each batch for exact storage and handling parameters.